Adient CEO has 5,896 shares withheld for taxes
Adient plc reported an insider transaction by President and CEO Jerome J. Dorlack.
Rhea-AI Filing Summary
Adient plc reported an insider transaction by President and CEO Jerome J. Dorlack. On February 8, 2026, 5,896 ordinary shares were withheld at $26.46 per share to cover taxes due upon the vesting of restricted stock units or performance share units. After this tax withholding, Dorlack directly owned 630,286 ordinary shares of Adient.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise Price or Tax Liability: 5,896 shares
Exercise Price or Tax Liability
1 txn
Insider
Dorlack Jerome J.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Ordinary Shares | 5,896 | $26.46 | $156K |
Holdings After Transaction:
Ordinary Shares — 630,286 shares (Direct)
Footnotes (1)
- F1. Withholding of shares to cover taxes due in connection with the vesting of restricted stock units or performance share units, as applicable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Adient (ADNT) CEO report on February 8, 2026?
Adient’s CEO Jerome J. Dorlack reported a tax-related share withholding on February 8, 2026. 5,896 ordinary shares were withheld at $26.46 per share to cover taxes triggered by vesting of restricted stock units or performance share units.
Was the Adient (ADNT) CEO’s Form 4 transaction a sale on the open market?
No, the Form 4 describes withholding of 5,896 shares to cover taxes, not an open-market sale. The footnote clarifies the shares were withheld in connection with vesting of restricted stock units or performance share units, a common administrative tax-settlement method.
What transaction code is used in the Adient (ADNT) CEO’s February 2026 Form 4 filing?
The Form 4 lists transaction code “F” for the February 8, 2026 event. This code corresponds to shares withheld to pay taxes, here involving 5,896 ordinary shares tied to the vesting of restricted stock units or performance share units.
What role does Jerome J. Dorlack hold at Adient (ADNT) according to this Form 4?
Jerome J. Dorlack is identified as both a Director and an Officer of Adient, serving as President and CEO. The Form 4 reflects his insider status while detailing the tax-related share withholding tied to his equity compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.